B HALL STRATEGIES, LLC
B HALL STRATEGIES, LLC is named as the registrant in 19 lobbying reports we hold for 2026-Q2, for 19 clients. 0 reports of 19 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE | 2026-Q2: No amount stated | 1 |
| TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. | 2026-Q2: $50,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS | 2026-Q2: $30,000 in income | 1 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA | 2026-Q2: $50,000 in income | 1 |
Lobbyists named in these reports
- JAMES BRYANT HALL II · 19 reports · earlier government job reported
Bills named, and how the House and the Senate voted
2 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 842Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act | Reported by committee | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
Issues named: Pharmacy (13), Medicare/Medicaid (5), Health Issues (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMAPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTISPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLCMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANYPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICAMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATIONPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF ORGANON, LLCPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALSMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP OBO SIEMENS HEALTHINEERSMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCEHealth Issues | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.